These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 5652215)

  • 1. The relative role of storage and synthesis of brain norepinephrine in the psychomotor stimulation evoked by amphetamine or by desipramine and tetrabenazine.
    Sulser F; Owens ML; Norvich MR; Dingell JV
    Psychopharmacologia; 1968; 12(4):322-32. PubMed ID: 5652215
    [No Abstract]   [Full Text] [Related]  

  • 2. On the role of norepinephrine biosynthesis in the central action of amphetamine.
    Dingell JV; Owens ML; Norvich MR; Sulser F
    Life Sci; 1967 Jun; 6(11):1155-62. PubMed ID: 6033624
    [No Abstract]   [Full Text] [Related]  

  • 3. On the role of rate of brain norepinephrine release in the antibenzoquinolizine action of desipramine.
    Sulser F; Soroko F
    Psychopharmacologia; 1965 Sep; 8(3):191-200. PubMed ID: 5885875
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of desmethylimipramine, protriptyline and (+)-amphetamine on fluorescence of central adrenergic neurons of rats pretreated with alpha-methyl-DOPA and tetrabenazine or reserpine.
    Carlsson A; Fuxe K; Hökfelt T
    Eur J Pharmacol; 1967 Dec; 2(3):196-201. PubMed ID: 5590343
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for a selective brain noradrenergic involvement in the locomotor stimulant effects of amphetamine in the rat.
    Ogren SO; Archer T; Johansson C
    Neurosci Lett; 1983 Dec; 43(2-3):327-31. PubMed ID: 6687006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat.
    Archer T; Fredriksson A; Jonsson G; Lewander T; Mohammed AK; Ross SB; Söderberg U
    Psychopharmacology (Berl); 1986; 88(2):141-6. PubMed ID: 3081924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p-Chloroamphetamine. Temporal relationship between psychomotor stimulation and metabolism of brain norepinephrine.
    Strada SJ; Sanders-Bush E; Sulser F
    Biochem Pharmacol; 1970 Sep; 19(9):2621-9. PubMed ID: 5478286
    [No Abstract]   [Full Text] [Related]  

  • 8. Tissue concentrations of p-hydroxynorephedrine in rats injected with d-amphetamine: effect of pretreatment with desipramine.
    Groppetti A; Costa E
    Life Sci; 1969 Jun; 8(11):653-65. PubMed ID: 5799285
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on adrenergic mechanisms in the action of desmethyl imipramine (DMI).
    Herman ZS
    Psychopharmacologia; 1970; 17(3):234-41. PubMed ID: 5446766
    [No Abstract]   [Full Text] [Related]  

  • 10. Paradoxical amphetamine effect in hyperactive rats in relation to norepinephrine metabolism.
    Ladisich W; Volbehr H; Matussek N
    Neuropharmacology; 1970 Jul; 9(4):303-10. PubMed ID: 5466110
    [No Abstract]   [Full Text] [Related]  

  • 11. Tetrabenazine-induced depletion of brain monoamines: mechanism by which desmethylimipramine protects cortical norepinephrine.
    Pettibone DJ; Pflueger AB; Totaro JA
    Eur J Pharmacol; 1984 Jul; 102(3-4):431-6. PubMed ID: 6149131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the effect of some central stimulants in mice pretreated with alpha-methyl-1-tyrosine.
    Menon MK; Dandiya PC; Bapna JS
    Psychopharmacologia; 1967; 10(5):437-44. PubMed ID: 5588338
    [No Abstract]   [Full Text] [Related]  

  • 13. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
    Segal DS; McAllister C; Geyer MA
    Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of imipramine, desipramine and monoamine oxidase inhibitors on the metabolism and psychomotor stimulant actions of d-amphetamine in mice.
    Lew C; Iversen SD; Iversen LL
    Eur J Pharmacol; 1971 May; 14(4):351-9. PubMed ID: 4400534
    [No Abstract]   [Full Text] [Related]  

  • 15. Different central mediation of the stimulant effects of amphetamine and its p-chloro analogue.
    Frey HH; Magnussen MP
    Biochem Pharmacol; 1968 Jul; 17(7):1299-307. PubMed ID: 5659777
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of amphetamine on locomotion in mice pretreated with desmethylimipramine, tetrabenazine or both.
    Weissman A
    Psychopharmacologia; 1972; 23(2):152-9. PubMed ID: 5022607
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.
    Carlsson A; Fuxe K; Hamberger B; Lindqvist M
    Acta Physiol Scand; 1966; 67(3):481-97. PubMed ID: 5967609
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of phencyclidine with drugs affecting noradrenaline metabolism in the rat brain.
    Tonge SR; Leonard BE
    Psychopharmacologia; 1972; 23(1):86-90. PubMed ID: 5018980
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
    Hollister AS; Breese GR; Cooper BR
    Psychopharmacologia; 1974 Mar; 36(1):1-16. PubMed ID: 4151923
    [No Abstract]   [Full Text] [Related]  

  • 20. The relative effects of d-amphetamine, imipramine and harmaline on tetrabenazine suppression of schedule-controlled behavior in the rat.
    McKearney JW
    J Pharmacol Exp Ther; 1968 Feb; 159(2):429-40. PubMed ID: 5638662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.